A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice, a Multicenter, Open-label, Randomized Controlled Clinical Study

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Severe obstructive jaundice caused by pancreatic head cancer usually requires preoperative biliary drainage, but its necessity and effectiveness are controversial, and specific strategies lack clear standards. This study proposed a new strategy for preoperative biliary drainage using serum prealbumin as the main evaluation index, and compared it with the traditional strategy using serum total bilirubin as the main evaluation index. Through a randomized, controlled, multicenter prospective study, we explored the effects of different drainage strategies on the incidence of in-hospital complications and long-term prognosis of patients with resectable pancreatic head cancer, guided clinical decisions on preoperative drainage time and surgical timing, and provided high-quality evidence-based medicine for preoperative biliary drainage of pancreatic head cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Pathological diagnosis of pancreatic head cancer, or clinical diagnosis of pancreatic head cancer after multidisciplinary discussion, clear presence of obstructive jaundice caused by pancreatic head tumor, and planned to undergo radical pancreaticoduodenectomy

• Preoperative imaging stage is resectable

• Baseline serum total bilirubin ≥ 250μmol/L, and no history of preoperative biliary drainage

• Age \>18 and ≤75 years old

• ECOG(Eastern Cooperative Oncology Group) physical score ≤ 2

• Signed informed consent, received preoperative endoscopic biliary drainage (ERCP) and radical surgery timing evaluation

Locations
Other Locations
China
Ruijin Hospital Shanghai Jiaotong University School of Medicine
RECRUITING
Shanghai
Contact Information
Primary
Jun Zhang, Ph.D&M.D
zj11477@rjh.com.cn
+86 18917530547
Time Frame
Start Date: 2024-08-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 360
Treatments
Active_comparator: Traditional strategy
Traditional preoperative biliary drainage strategy with total bilirubin as the main indicator
Experimental: Modified strategy
Modified preoperative biliary drainage strategy with prealbumin as the main indicator
Related Therapeutic Areas
Sponsors
Leads: Ruijin Hospital

This content was sourced from clinicaltrials.gov